AGIOS PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AGIOS PHARMACEUTICALS, INC. has filed 1,291 SEC EDGAR filings since 01 Jul 2008

SEC filing history

Showing 51-75 of 1,000 matching filings.

Per page
25
Current page
3
4

FORM 4

Filing date
03 Mar 2026
Reporting date
01 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2026
Reporting date
01 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Mar 2026
Reporting date
01 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87570

SCHEDULE 13G filing

Filing date
17 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87570

SCHEDULE 13G/A filing

Filing date
09 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87570

SCHEDULE 13G filing

Filing date
09 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Jan 2026
Reporting date
05 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
05 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2026
Reporting date
30 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .